November 16, 2016

ASCO, CAP, and ASCP Issue Joint Guideline on HER2 Testing in Gastroesophageal Cancers

BY Dr. Keith J. Kaplan

Anatomic Pathology, Clinical Laboratories, General Healthcare News, Laboratory Management & Operations, Pathology News, Standards and Guidelines

The American Society of Clinical Oncology (ASCO), the College of American Pathologists (CAP) and the American Society for Clinical Pathology (ASCP) have issued a joint guideline on HER2 testing for patients with gastroesophageal cancers. Read the full guideline and watch a video summary.

Philips and AWS expand strategic collaboration to advance HealthSui...

Philips: Cloud-enabled integrated diagnostics portfolio aims to unify workflows, improve access to critical insights, and drive better outcomes for patients Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global...

ASCO, CAP, and ASCP Issue Joint Guideline on HER2 Testing in Gastroesophageal Cancers

next article

Philips and AWS expand strategic collaboration to advance HealthSui...

platinum partners

gold partners

Silver Partners

Media Partners